Investing
The company is looking to test the product in the U.S. and Europe, with the goal of gaining market approval for both regions by 2023.
HIMSSCast caught up with part of the Rock Health team to look back at an eventful six months of investor activity and look ahead to the rest of 2020.
News of the potential sale or merger with a special purpose acquisition company appears at the same time as one-on-one counseling and a key strategic hire.
The startup provides users with price transparency tools and a Visa card for healthcare payments at cash rates.
The company heavily relies on telemedicine and digital services to provide care.
The funding will aim to facilitate the company’s technology to treat conditions such as diabetes, insomnia, anxiety and obesity.
The new round was led by Motley Fool Ventures with participation from Zoll Medical Corporation, UH Ventures and Gray Ferry Capital.
The startup combines free assessments and in-person therapy with telehealth and digital care-coordination.
Also: Noteworth's $5 million seed round, Qualio's $11 million Series A and Cohere Health's $10 million Series A.
The funding will support NanoVation in developing a device which targets patients with chronic obstructive pulmonary disease (COPD).